The White House is unveiling an aggressive drug pricing strategy targeting pharmaceutical companies, promising to dramatically cut prescription drug costs for American consumers.
Donald Trump condemned the current pricing system as a “redistribution” that has allowed drugmakers to exploit US patients and signed an executive order that he says will lead to matching lower drug prices abroad.
